| Typicality: | 0.346 |
| Saliency: | 0.226 |
| over the duration of the study | 8 | temporal |
| in pain | 7 | other |
| compared to placebo | 5 | other |
| subject → show → significant reduction | 8 |
| subject → demonstrate → significant reductions | 3 |
| subject → see → significant reduction | 3 |
| subject → show → significant reductions | 3 |
| negative | neutral | positive |
| 0.041 | 0.603 | 0.356 |
| Raw frequency | 17 |
| Normalized frequency | 0.226 |
| Modifier score | 0.500 |
| Perplexity | 63.681 |